Debate: AI's limitations in curing diseases and the viability of biosimulation
rand_longevity · x · 2026-08-18
- Skeptic's View: AI cannot cure all diseases in 5-10 years due to long clinical trials (7+ years), drug development timelines (10-15 years), high failure rates in AI drug discovery, and insufficient/low-quality biological data.
- Optimist's View: Biosimulation is the likely path forward. While simulating entire cells is currently implausible, discovering overlying mechanisms of aging offers a great chance for success.
- Key Issues: The debate centers on the reproducibility crisis in biological data, the complexity of biological systems, and whether simulation can replace wet lab studies.
Related event: AI May Conquer Math but Not Biology Soon, Debate Heats Up(3 posts)→
More from AGI Musings
- Dev argues AI is great at assets and code but bad at designing game mechanics that feel good — rms80 · 2026-10-03
- CAS Five-Year Plan gives AI for Science its own chapter, setting up a US-vs-China metascience bet — teortaxesTex · 2026-10-03
- Draft standard for autonomous labs emerges as AI-driven science heats up — Afinetheorem · 2026-10-03
- After a diagnosis, use LLMs as agents to dissect pathology, treatments and trials — louisvarge · 2026-10-03
- Blogger defends AI-generated adult content: harms no one, labels optional — JHochderffer · 2026-10-03
- PowerShell creator Jeffrey Snover: AI inference costs collapsed, would short frontier models — dfinke · 2026-10-03